These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32000385)

  • 21. C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients: A meta-analysis.
    Tian R; Tian M; Wang L; Qian H; Zhang S; Pang H; Liu Z; Fang L; Shen Z
    Cytokine; 2019 May; 117():59-64. PubMed ID: 30826600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis: Circulating vitamin D and ovarian cancer risk.
    Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
    Gynecol Oncol; 2011 May; 121(2):369-75. PubMed ID: 21324518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin Use and Mortality in Women With Ovarian Cancer: A Meta-Analysis.
    Man X; Wang B; Tan Y; Yang X; Zhang S
    Front Oncol; 2020; 10():575831. PubMed ID: 33598421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
    Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
    Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies.
    Jayedi A; Rahimi K; Bautista LE; Nazarzadeh M; Zargar MS; Shab-Bidar S
    Heart; 2019 May; 105(9):686-692. PubMed ID: 30700522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
    Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
    Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies.
    Yan-Hong H; Jing L; Hong L; Shan-Shan H; Yan L; Ju L
    BMC Public Health; 2015 Mar; 15():223. PubMed ID: 25885863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum C-reactive protein in the differential diagnosis of ovarian masses.
    Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
    Wu YS; Shui L; Shen D; Chen X
    Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
    Shi LF; Wu Y; Li CY
    Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis.
    Johnston SC; Colford JM; Gress DR
    Neurology; 1998 Aug; 51(2):411-8. PubMed ID: 9710012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
    Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
    Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiorespiratory fitness, C-reactive protein and lung cancer risk: A prospective population-based cohort study.
    Pletnikoff PP; Laukkanen JA; Tuomainen TP; Kauhanen J; Rauramaa R; Ronkainen K; Kurl S
    Eur J Cancer; 2015 Jul; 51(11):1365-70. PubMed ID: 26008754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary fat and fatty acid intake and epithelial ovarian cancer risk: evidence from epidemiological studies.
    Hou R; Wu QJ; Gong TT; Jiang L
    Oncotarget; 2015 Dec; 6(40):43099-119. PubMed ID: 26515595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of high-sensitivity C-reactive protein serum levels in the prognosis for patients with stroke: a meta-analysis.
    Chen L; Wang M; Yang C; Wang Y; Hou B
    Front Neurol; 2023; 14():1199814. PubMed ID: 37342777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis.
    Yoon SH; Kim SN; Shim SH; Kang SB; Lee SJ
    Eur J Cancer; 2016 Mar; 55():38-46. PubMed ID: 26773418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-analysis of epidemiological studies.
    Luan NN; Wu L; Gong TT; Wang YL; Lin B; Wu QJ
    Cancer Causes Control; 2015 Jan; 26(1):65-78. PubMed ID: 25359305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A predictive role of C-reactive protein in colorectal cancer risk: an updated meta-analysis from 780,985 participants and 11,289 cancer cases.
    Han L; Guo Y; Ren D; Hui H; Li N; Xie X
    Int J Colorectal Dis; 2023 May; 38(1):121. PubMed ID: 37160817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies.
    Yang X; Zhang D; Zhao Y; Liu D; Li Q; Guo C; Tian G; Han M; Qie R; Huang S; Zhou Q; Zhao Y; Feng Y; Wu X; Zhang Y; Li Y; Wu Y; Cheng C; Hu D; Sun L
    J Hum Hypertens; 2021 Dec; 35(12):1149-1158. PubMed ID: 33980977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies.
    Zhang D; Zhao Y; Wang T; Xi Y; Li N; Huang H
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27860198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.